SRTS

Sensus Healthcare, Inc.

$3.30

3.77%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.

Source: Yahoo Finance
AI summary

Price & performance

1M+0.0%
3M-0.7%
YTD-28.8%
1Y-20.9%
52-week range—
Beta0.82
Full chart and returns against a benchmark

Q-Score

48/ 100

Quality against peers; 50 is the peer median.

Growth30
Risk52
Performance57
Valuation51
Profitability41
Leverage69
Sentiment35
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$27.5M-34.3%
Net income-$7.7M-216.1%
Net margin-28.1%-44.0 pts
Historical fundamentals

Red flags in filings

1active red flag
Auditor changeJan 20, 2026
Filings, findings and the timeline

Revenue exposure

8%of revenue from outside the US
United States92%
China7%
Other0%
Largest customer52%
Regions, segments, customers and suppliers

Valuation

SRTSIndustryP/E—29.61P/S3.103.49EV/EBITDA—18.38P/B1.473.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 12next report, after the close
EPS estimate$-0.04
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate